Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NYSE:LLY NASDAQ:META NYSE:MRK NASDAQ:NVDA NASDAQ:TSLA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$216.02+0.7%$208.72$181.71▼$244.81$378.98B0.326.29 million shs5.41 million shsLLYEli Lilly and Company$1,066.59+2.4%$942.87$623.78▼$1,133.95$980.96B0.483.50 million shs3.47 million shsMETAMeta Platforms$610.26+0.5%$617.68$520.26▼$796.25$1.54T1.2516.26 million shs11.67 million shsMRKMerck & Co., Inc.$122.55+5.8%$115.92$75.40▼$125.14$302.33B0.188.53 million shs14.75 million shsNVDANVIDIA$215.33-1.9%$196.10$129.16▼$236.54$5.31T2.25164.89 million shs168.17 million shsTSLATesla$426.01+2.0%$387.76$273.21▼$498.83$1.57T1.7955.73 million shs45.93 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.54%+2.60%+7.78%-3.97%+18.86%LLYEli Lilly and Company+2.37%+6.11%+15.81%+5.76%+47.26%METAMeta Platforms+0.47%-0.65%-9.55%-6.92%-3.97%MRKMerck & Co., Inc.+5.78%+10.05%+8.58%+0.41%+59.38%NVDANVIDIA-1.90%-4.43%+6.34%+13.44%+63.38%TSLATesla+1.95%+0.89%+9.94%+3.45%+27.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$216.02+0.7%$208.72$181.71▼$244.81$378.98B0.326.29 million shs5.41 million shsLLYEli Lilly and Company$1,066.59+2.4%$942.87$623.78▼$1,133.95$980.96B0.483.50 million shs3.47 million shsMETAMeta Platforms$610.26+0.5%$617.68$520.26▼$796.25$1.54T1.2516.26 million shs11.67 million shsMRKMerck & Co., Inc.$122.55+5.8%$115.92$75.40▼$125.14$302.33B0.188.53 million shs14.75 million shsNVDANVIDIA$215.33-1.9%$196.10$129.16▼$236.54$5.31T2.25164.89 million shs168.17 million shsTSLATesla$426.01+2.0%$387.76$273.21▼$498.83$1.57T1.7955.73 million shs45.93 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.54%+2.60%+7.78%-3.97%+18.86%LLYEli Lilly and Company+2.37%+6.11%+15.81%+5.76%+47.26%METAMeta Platforms+0.47%-0.65%-9.55%-6.92%-3.97%MRKMerck & Co., Inc.+5.78%+10.05%+8.58%+0.41%+59.38%NVDANVIDIA-1.90%-4.43%+6.34%+13.44%+63.38%TSLATesla+1.95%+0.89%+9.94%+3.45%+27.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.88Moderate Buy$253.4317.32% UpsideLLYEli Lilly and Company 2.87Moderate Buy$1,220.3714.42% UpsideMETAMeta Platforms 2.89Moderate Buy$840.1937.68% UpsideMRKMerck & Co., Inc. 2.68Moderate Buy$128.184.59% UpsideNVDANVIDIA 3.00Buy$303.2740.84% UpsideTSLATesla 2.34Hold$395.20-7.23% DownsideCurrent Analyst Ratings BreakdownLatest LLY, MRK, ABBV, TSLA, META, and NVDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026LLYEli Lilly and Company The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$1,283.005/22/2026NVDANVIDIA Citic SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$242.00 ➝ $315.005/22/2026NVDANVIDIA Daiwa Securities GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$215.00 ➝ $255.005/22/2026NVDANVIDIA CICC ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$240.60 ➝ $268.305/21/2026LLYEli Lilly and Company Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$1,350.005/21/2026LLYEli Lilly and Company Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform5/21/2026NVDANVIDIA Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOutperform$300.00 ➝ $500.005/21/2026NVDANVIDIA BenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$250.00 ➝ $335.005/21/2026NVDANVIDIA EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$352.00 ➝ $413.005/21/2026NVDANVIDIA Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$240.00 ➝ $270.005/21/2026NVDANVIDIA Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$220.00 ➝ $255.00(Data available from 5/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$62.82B6.08$15.26 per share14.16($3.74) per share-57.76LLYEli Lilly and Company$65.18B15.41$25.74 per share41.44$33.13 per share32.19METAMeta Platforms$214.96B7.18$37.74 per share16.17$96.33 per share6.34MRKMerck & Co., Inc.$65.77B4.60$12.07 per share10.15$18.60 per share6.59NVDANVIDIA$215.94B24.13$4.63 per share46.47$8.08 per share26.65TSLATesla$94.83B16.87$2.72 per share156.89$22.56 per share18.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.03106.4113.250.745.79%-576.45%13.39%7/30/2026 (Estimated)LLYEli Lilly and Company$20.64B$28.1537.8924.111.1334.98%105.77%23.76%8/5/2026 (Estimated)METAMeta Platforms$60.46B$27.5122.1817.431.0732.84%36.93%23.09%7/29/2026 (Estimated)MRKMerck & Co., Inc.$18.25B$3.5534.5212.532.6113.59%27.55%10.73%8/4/2026 (Estimated)NVDANVIDIA$120.07B$4.9032.9820.160.6862.97%96.94%72.16%N/ATSLATesla$3.79B$1.09390.83249.1316.503.95%4.89%2.93%7/22/2026 (Estimated)Latest LLY, MRK, ABBV, TSLA, META, and NVDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2026Q1 2027NVDANVIDIA$1.76$1.87+$0.11$2.39$78.42 billion$81.62 billion4/30/2026Q1 2026LLYEli Lilly and Company$6.97$8.55+$1.58$8.26$17.82 billion$19.80 billion4/30/2026Q1 2026MRKMerck & Co., Inc.-$1.47-$1.28+$0.19-$1.72$15.85 billion$16.29 billion4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billion4/29/2026Q1 2026METAMeta Platforms$6.67$10.44+$3.77$10.44$55.56 billion$56.31 billion4/23/2026Q1 2026TSLATesla$0.39$0.41+$0.02$0.13$22.96 billion$22.39 billion2/25/2026Q4 2026NVDANVIDIA$1.54$1.62+$0.08$1.76$65.56 billion$68.13 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.923.20%+6.80%340.89%53 YearsLLYEli Lilly and Company$6.920.65%+15.18%24.58%11 YearsMETAMeta Platforms$2.100.34%N/A7.63%1 YearsMRKMerck & Co., Inc.$3.402.77%+5.75%95.77%14 YearsNVDANVIDIA$0.040.02%+14.87%0.82%1 YearsTSLATeslaN/AN/AN/AN/AN/ALatest LLY, MRK, ABBV, TSLA, META, and NVDA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2026NVDANVIDIAquarterly$0.250.45%6/4/20266/4/20266/26/20265/4/2026LLYEli Lilly and Companyquarterly$1.730.69%5/15/20265/15/20266/10/20262/25/2026NVDANVIDIAquarterly$0.010.02%3/11/20263/11/20264/1/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.68LLYEli Lilly and Company1.261.501.10METAMeta Platforms0.242.352.35MRKMerck & Co., Inc.1.021.301.06NVDANVIDIA0.043.443.24TSLATesla0.092.041.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%LLYEli Lilly and Company82.53%METAMeta Platforms79.91%MRKMerck & Co., Inc.76.07%NVDANVIDIA65.27%TSLATesla66.20%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%LLYEli Lilly and Company0.14%METAMeta Platforms13.53%MRKMerck & Co., Inc.0.17%NVDANVIDIA4.17%TSLATesla19.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableLLYEli Lilly and Company50,000941.74 million940.42 millionOptionableMETAMeta Platforms78,8652.53 billion2.19 billionOptionableMRKMerck & Co., Inc.75,0002.47 billion2.47 billionOptionableNVDANVIDIA42,00024.20 billion23.21 billionOptionableTSLATesla134,7853.76 billion3.01 billionOptionableLLY, MRK, ABBV, TSLA, META, and NVDA HeadlinesRecent News About These CompaniesFormer Tesla president shares the secret to success he learned from his former boss, Elon Musk: ‘He demands to only work with world-class talent’44 minutes ago | finance.yahoo.comElon Musk has given up on solar power (on Earth)44 minutes ago | finance.yahoo.comTesla Robotaxi Problems in Texas: What Could It Mean for TSLA Stock?44 minutes ago | fool.comDow Jones Futures: Market Bets On Iran Deal; Tesla, These Five AI Plays Are At Buy Points44 minutes ago | finance.yahoo.comThis "Magnificent Seven" Stock Is the Worst Performer of 2026. Is It Finally a Buy?44 minutes ago | fool.comTesla Stock at Crossroads as Musk Bets Get Bigger2 hours ago | tipranks.comHow big tech got its way on Trump's AI executive order3 hours ago | theguardian.comTesla Carbon Fiber Accessories & Steering Wheels: Upgrade Your Tesla with Premium Style3 hours ago | talkmarkets.comTesla Robotaxi Problems in Texas: What Could It Mean for TSLA Stock?3 hours ago | fool.comIs Tesla, Inc. (TSLA) One of the Best ARK Stocks to Buy Right Now?May 23 at 7:29 AM | finance.yahoo.comFormer Tesla president shares the secret to success he learned from his former boss, Elon Musk: ‘He demands to only work with world-class talent’May 23 at 7:10 AM | fortune.comGPS Wealth Strategies Group LLC Sells 9,539 Shares of Tesla, Inc. $TSLAMay 23 at 7:03 AM | marketbeat.comMarketBeat Week in Review – 05/18 - 05/22 (TSLA)...May 23 at 7:00 AM | marketbeat.com185,000 Shares in Tesla, Inc. $TSLA Purchased by Mizuho Markets Americas LLCMay 23 at 6:53 AM | marketbeat.comKarras Company Inc. Takes $2.44 Million Position in Tesla, Inc. $TSLAMay 23 at 6:31 AM | marketbeat.com1,256 Shares in Tesla, Inc. $TSLA Acquired by Platt Wealth Management LLCMay 23 at 6:31 AM | marketbeat.comTesla, Inc. $TSLA Holdings Lifted by EverSource Wealth Advisors LLCMay 23 at 4:41 AM | marketbeat.comEvoke Wealth LLC Increases Stock Position in Tesla, Inc. $TSLAMay 23 at 4:24 AM | marketbeat.comBerkshire Capital Holdings Inc. Lowers Stock Position in Tesla, Inc. $TSLAMay 23 at 3:36 AM | marketbeat.comAdvisory Alpha LLC Raises Stock Holdings in Tesla, Inc. $TSLAMay 23 at 3:14 AM | marketbeat.comDow Jones Futures: Stock Market Rebounds To Highs; Tesla, These Five AI Plays Are At Buy PointsMay 22 at 6:31 PM | investors.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesApple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 2026AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?By Thomas Hughes | April 29, 2026Industrial Chips Are in Rally Mode—5 Ways to PlayBy Thomas Hughes | April 27, 2026Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand NowBy Leo Miller | May 11, 2026What the FDA's Latest Proposal Means for Lilly, Novo, and HimsBy Leo Miller | May 7, 2026LLY, MRK, ABBV, TSLA, META, and NVDA Company DescriptionsAbbVie NYSE:ABBV$216.02 +1.52 (+0.71%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$216.39 +0.37 (+0.17%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Eli Lilly and Company NYSE:LLY$1,066.59 +24.94 (+2.39%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$1,065.00 -1.59 (-0.15%) As of 05/22/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.Meta Platforms NASDAQ:META$610.26 +2.88 (+0.47%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$607.36 -2.90 (-0.48%) As of 05/22/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, CaliforniaMerck & Co., Inc. NYSE:MRK$122.55 +6.67 (+5.76%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$122.52 -0.02 (-0.02%) As of 05/22/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.NVIDIA NASDAQ:NVDA$215.33 -4.18 (-1.90%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$214.28 -1.05 (-0.49%) As of 05/22/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.Tesla NASDAQ:TSLA$426.01 +8.16 (+1.95%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$423.67 -2.34 (-0.55%) As of 05/22/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
